Skip to content

Study the effect of Chaturbeeja Churana Ghanvati in Primary Dysmenorrhea (Udavartini Yonivyapad)

A Single Arm Clinical Study to Evaluate the Efficacy Of Chaturbeeja Churna Ghanvati in The Management of Primary Dysmenorrhea (Udavartini Yonivyapad ) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066715
Enrollment
40
Registered
2024-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Dr Bharti
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient’s suffering from Painful menstruation for more than 3 consecutive cycles. 2.Age groups between 12 to 25 years shall be selected (Inclusive of both Years)

Exclusion criteria

Exclusion criteria: 1.Known case of Secondary dysmenorrhea. 2.Any pelvic pathology like Fibroid, Adenomyosis, Ovarian tumors, Endometriosis, Pelvic inflammatory disease. 3.Women diagnosed with congenital anomalies of reproductive tract, pelvic infections. 4.Other medical disorders which make patient at high risk- like Epilepsy, Anaemia Hb less than 9gm/dl, Heart disease, Diabetes.

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Chaturbheeja Churna Ghanvati in the management of Dysmenorrohea on the bais of VAS Scale and WaLIDD Scale for Pain.Timepoint: 7 days before menstrual cycle upto three days during menstrual cycle for 3 consecutive menstrual cycles

Secondary

MeasureTime frame
To study other effects of Chaturbeeja Churna Ghanvati in Primary Dysmenorrhoea, If any.Timepoint: 7 days before menstrual cycle upto three days during menstrual cycle for 3 consecutive menstrual cycles

Countries

India

Contacts

Public ContactDr Pradnya Shirke

Dr D Y Patil College of Ayurved and Research Centre

pradnyashirke2@gmail.com9623446110

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026